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RIASSUNTO 
Premessa: la stenosi valvolare aortica (AVS) sta diventando sempre più frequente nella 
popolazione anziana, coinvolgendo circa il 13.2% dei soggetti sopra i 75 anni. Oltre a 
compromettere la qualità della vita, la AVS di grado severo non trattata porta alla morte in 
un tempo relativamente breve. La storia naturale della AVS può essere modificata dalla 
sostituzione della valvola aortica (AVR). I progressi nelle tecniche operatorie e 
anestesiologiche hanno ampliato negli ultimi anni l’accesso all’intervento chirurgico a 
pazienti sempre più anziani e sempre più fragili. In letteratura gli studi hanno finora 
valutato l’efficacia della AVR nel paziente anziano in termini di mortalità peri- e post-
operatoria, mentre mancano dati circa l’esito dell’intervento sulla salute globale del 
paziente fragile a medio termine.  
Scopo dello studio: lo scopo del nostro studio era valutare nel soggetto anziano l’impatto 
dell’intervento di AVR sulla performance fisica, sullo stato cognitivo e sulla qualità di vita 
a distanza di 45 giorni, tre e sei mesi dall’intervento chirurgico.  
Soggetti e metodi: in collaborazione con l’U.O. Cardiochirurgia, secondo un disegno 
osservazionale longitudinale sono stati studiati 46 pazienti di età > 70 anni affetti da AVS 
per i quali era stata posta indicazione all’AVR. I soggetti sono stati valutati prima 
dell’intervento chirurgico (T0) e dopo l’intervento chirurgico a 45 giorni (T1), a tre mesi 
(T2) e a 6 mesi (T3). In tutte le visite i soggetti sono stati sottoposti a una valutazione 
geriatrica multidimensionale, comprensiva di esame clinico, valutazione dell’autonomia 
funzionale (Activites of Daily Living e  Instrumental Activites of Daily Living Scales), dello 
stato cognitivo (Mini Mental State Examination, Montreal Cognitive Assessment), del tono 
dell’umore (Geriatric Depression Scale), della qualità di vita (Short-Form 36 items Health 
Survey, SF-36) e della performance fisica (Short Physical Performance Battery, Gait 
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Speed, Six minute Walking Test, misurazione della forza massimale degli arti superiori e 
inferiori). 
Risultati: dei 46 pazienti inclusi nello studio in questo lavoro sono stati considerati solo i 
22 soggetti che hanno completato il follow-up a 6 mesi. Rispetto alla valutazione 
preoperatoria, al follow-up dei 45 giorni era evidente un significativo peggioramento nei 
parametri nutrizionali (BMI,circonferenza del braccio, punteggio MNA) e dei test di 
performance fisica (forza massimale di prensione della mano, forza di flesso-estensione 
degli arti inferiori e test isometrico della forza degli arti inferiori). Al follow-up dei 6 mesi 
MNA, MMSE, MoCA, SPPB miglioravano significativamente, raggiungendo valori 
superiori a quelli basali. La forza degli arti superiori e inferiori non si modificava 
significativamente 6 mesi dopo l’intervento rispetto al basale. Per ciò che concerne la 
qualità di vita, i punteggi all’SF-36 rimanevano pressoché stabili a 45 giorni mentre 
miglioravano significativamente al controllo a 3 e a 6 mesi.   
Considerando la variazione della velocità del passo tra la valutazione basale e quella a 6 
mesi, i soggetti che presentavano un miglioramento nel follow up, rispetto agli altri 
soggetti al basale presentavano valori più bassi di forza degli arti superiori e inferiori, di 
velocità del passo e percorrevano una distanza significativamente inferiore al 6-MWT.  
Conclusioni: i dati di questo studio evidenziano che nei pazienti anziani affetti da AVS, la 
sostituzione valvolare aortica migliora lo stato nutrizionale, le facoltà cognitive, il tono 
dell’umore, la performance fisica e la qualità di vita. La forza degli arti inferiori e superiori 
invece mantiene a 6 mesi valori non diversi da quelli pre-operatori. I soggetti che 
sembrano beneficiare maggiormente dal punto di vista funzionale della AVR sono quelli 
più compromessi a basale dal punto di vista della performance fisica. 
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ABSTRACT  
Background: aortic valve stenosis (AVS) is becoming more and more common in the 
elderly population, involving around 13.2% of subjects older than 75 years. In addition to 
worsening quality of life, untreated severe AVS has been associated with high short term 
mortality rate. However, these adverse outcomes could be modified by aortic valve 
replacement (AVR). In recent years, in particular, newer surgery procedures and 
anesthesiological techniques have allowed also older and frailer patients access to AVR 
procedures. Previous studies have evaluated the effectiveness of AVR in older subjects in 
terms of peri- and post-operative mortality, but its impact on frail patients’ global health 
has been scarcely investigated.  
Aim of the study: the aim of our study was to evaluate the impact of AVR procedure on 
older patients’ physical performance, cognitive status and quality of life at 45 days, three 
and six months after surgery. 
Subjects and methods: this prospective study included 46 patients over 70 years, enrolled 
in collaboration with the Department of Cardiac Surgery of the University of Padova. All 
subjects were affected by AVS, and were recommended to undergo AVR. Study 
participants were evaluated with a multidimensional geriatric assessment before AVR  
(T0) and 45 days (T1), three (T2) and six months (T3) after surgery. In particular, for each 
participant we collected data on clinical examination, self-sufficiency (using the Activites 
of Daily Living and Instrumental Activites of Daily Living scales), cognitive status (using 
the Mini Mental State Examination and  the Montreal Cognitive Assessment), presence of 
depressive symptom (through the Geriatric Depression Scale), quality of life (using the 
Short-Form 36 items Health Survey) and physical performance (through the Short Physical 
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Performance Battery, gait speed, 6-minute walking test, and measurements of upper and 
lower limbs strength). 
Results: of the initial sample of 46 patients, 22 reached the 6-month follow-up and were 
included in the study. Compared with the pre-operative evaluation, at T1 we observed a 
significant decline in nutritional status (BMI, arm circumference, MNA score) and in 
physical performance (SPPB, handgrip strength, lower limb flexion-extension and 
isometric strength). At T3, MMSE, MoCA, MNA and SPPB scores improved significantly 
from baseline. Upper and lower limbs strength at 6-month follow up was not significantly 
different from baseline. Quality of life remained nearly stable at T1, but improved  
significantly at T2 and T3.  
Considering the variation in gait speed from baseline to 6-month follow up, subjects that 
showed an improvement in this item compared to worsening subjects, at baseline had 
lower values of handgrip and limbs strength, gait speed and 6-MWT distance.   
Conclusions: our results show that in older AVS patients, AVR have a positive impact on 
nutrition, physical performance, cognitive functioning, mood and quality of life, whereas it 
does not have any significant impact on limbs muscle strength. 
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INTRODUCTION  
The elderly population is the fastest growing demographic in Western countries, with the 
world population of people over the age of 60 years expected to double to 2 billion by the 
year 2015 and those over the age of 80 years to increase 26-fold (1).  
As the population ages, the incidence of age-related comorbidities as diabetes mellitus, 
chronic obstructive pulmonary disease, peripheral vascular disease, renal disease, 
cerebrovascular disease, and cardiovascular disease increases. 
Cardiovascular disease occur in approximately one-quarter of the population over the age 
of 75 years. Also the prevalence of valvular heart disease (VHD) increases with age, with 
aortic valve stenosis (AVS) and mitral regurgitation being the most prevalent valvular 
disorders in the elderly (2,3). Population-based studies report that age-adjusted prevalence 
of moderate or severe AVS is about 2.5%, with a significant influence by age: <2% 
prevalence in those <65 years of age and 13.2% in those ≥75 years of age (3,4).  
 
Pathophysiology of AVS 
The pathophysiology of degenerative calcific aortic stenosis is the result of a biologically 
active process with characteristic features of an osteoblast phenotype (5). Risk factors for 
disease progression mirror those of coronary artery disease, with risk factors including 
hypertension, hyperlipidemia, diabetes, smoking, and renal dysfunction. An inflammatory 
basis for aortic stenosis is supported by studies demonstrating increasing 18-
fluorodeoxyglucose levels, which is a marker of macrophage activity, with increasing 
valve stenosis severity (6). 
An increase in the aortic valve gradient results in pressure overload and concentric left 
ventricular hypertrophy with preservation of left ventricular cavity size and ejection-
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fraction. Nevertheless, the hypertrophy and associated fibrosis (7) contribute to left 
ventricular diastolic dysfunction and increased filling pressures.  
 
Symptoms of AVS 
The three cardinal symptoms of aortic stenosis indicating a need for intervention are 
angina, exertional syncope or presyncope, and heart failure (e.g. exertional cardiac 
dyspnoea, orthopnea, paroxysmal nocturnal dyspnoea, pedal oedema). 
Angina is the result of increased myocardial muscle and increased myocardial demand 
with limited blood supply with or without coronary artery disease. Exertional angina may 
be present in up to 50% of patients with aortic stenosis despite the absence of obstructive 
coronary artery disease (8). Exertional syncope or presyncope is the result of peripheral 
vasodilation with an inability of the heart to increase stroke volume due to the obstruction 
in left ventricular outflow. Finally, heart failure is the result of left ventricular hypertrophy 
with fibrosis and diastolic dysfunction, with increased filling pressure, often despite 
preserved left ventricular ejection fraction (7). 
 
Criteria for climatically significant AVS 
The normal aortic valve has three thin highly mobile leaflets that provide a valve opening 
of 3 to 4 cm
2
 and minimal gradient (<10 mmHg). Progression of aortic stenosis in the early 
stages is very slow with estimates of lumen loss of 0.10 cm
2
 per year (9) and increase in 
peak gradient of 10 mmHg per year (10), but there is a great variation among individual 
patients. There is considerable valve area reserve. Symptoms of aortic stenosis do not 
develop until there has been 60% to 75% loss of valve area to less than 1.0 cm
2
. As a 
result, many patients remain asymptomatic for decades, with the symptoms of dyspnoea, 
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angina and syncope to occur in the sixth to eighth decade of life (11). In older people these 
symptoms result in disability, recurrent hospitalizations, impairment in quality of life, and 
finally death.  
 
Measurement of AVS 
Resting thranstoracic echocardiography readily allows for assessment of left ventricular 
wall thickness, cavity size, and regional-global systolic function. In addition, aortic valve 
morphology can be assessed. Finally, Doppler echocardiography allows for an accurate 
noninvasive assessment of aortic valve peak and mean gradients, estimation of aortic valve 
area, and assessment of aortic regurgitation. The transthoracic echocardiography peak 
aortic valve gradient is slightly higher than the gradient reported at cardiac catheterization 
as it measures the maximal instantaneous peak gradient between the aorta and the left 
ventricle, while invasive measurements report the difference between the peak left 
ventricular pressure and the peak aortic pressure. The mean gradients derived by both 
methods are similar. 
If Doppler echocardiography is unable to assess the valve, other options include planimetry 
using 2- or 3- dimensional transesophageal echocardiography, computed tomography, and 
cardiovascular magnetic resonance. All of these methods offer good correlation with 
thranstoracic echocardiography and cardiac catheterization but with additional costs, 
invasiveness, or radiation exposure. 
Because the presence of angina may be related to aortic stenosis or coexistent coronary 
artery disease and because patients with aortic stenosis often have typical risk factors for 
coronary artery disease, screening coronary angiography is recommended for most adult 
patients prior to aortic valve surgery (12,13). 
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Management of significant AVS 
Medical therapies for degenerative VHD primarily consist in symptom control but they 
have with little effect on mortality, with 2-year mortality following the onset of symptoms 
as high as 80% (14). Aortic valve replacement therapy is the only treatment that has proved 
helpful in strengthening the survival prospects of these patients (15), with 3-year survival 
following surgery of 87% (14).  
Class I indications for aortic valve surgery as recommended by both the ACC/AHA and 
the European Society of Cardiology and European Association for Cardio-Thoracic 
Surgery (ESC/EACTS) guidelines (12,13) include symptomatic patients with severe aortic 
stenosis (aortic valve area <1.0 cm
2
 or indexed aortic valve area, i.e. aortic valve area 
divided by body surface area, <0.6 cm
2
/m
2
) and asymptomatic patients with depressed 
ejection fraction (<50%). 
Of the three cardinal symptoms, heart failure is the most ominous with survival of less than 
a year after heart failure symptoms without valve replacement; for patients who present 
with exertional syncope, survival is less than two years after the development of symptoms 
without valve replacement (16). 
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PREMISE OF THE STUDY 
Aortic valve stenosis (AVS) is becoming more and more common in the elderly 
population, involving around 13.2% of subjects older than 75 years. The prevalence of 
valvular heart disease (VHD) increases with age, with aortic valve stenosis (AVS) and 
mitral regurgitation being the most prevalent valvular disorders in the elderly (2-4).  
AVS remains asymptomatic for decades, with the symptoms of dyspnoea, angina and 
syncope to occur in the sixth to eighth decade of life (11).  In older people these symptoms 
can result in disability, recurrent hospitalizations, impairment in quality of life, and finally 
death. These adverse outcomes could be modified by the aortic valve replacement (AVR). 
In recent years, in particular, surgery procedures and anesthesiological techniques have 
allowed also older and frailer patients access to AVR procedures.  
In the elderly, AVR is associated with significant morbidity and mortality due to the global 
complexity (or frailty) of this class of patients (17). Frailty is characterized by impaired 
physiologic response and decreased resistance to stressors, due to a lack of physiological 
reserves across multiple organ systems. The assessment of frailty requires the evaluation of 
different domains, including physical function (for example, evaluating standing balance, 
gait speed, the distance covered by the subject walking for 5 or 6 minutes), 
neuropsychological and nutritional status, and social factors.  
Physical performance and frailty are predictors of disability and mortality (18-24), also in 
relation to cardiac surgery in elderly patients (25). Furthermore, the relevance of 
performance in the elderly is highlighted also by the fact that including a functional 
parameter as gait speed to the STS score in patients undergoing cardiac surgery, improved 
2- to 3-fold risk prediction of in-hospital morbidity and mortality (26).  
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Hence frailty can be used to identify subjects at greater risk for perioperative complications 
and mortality. Nevertheless, since that AVS itself can be a cause of disability, frailty and 
poor quality of life in elderly patients, the correction of valvular defect may modify and 
improve performance status in older patients, which is also the aim of AVR. Consequently, 
the evaluation of AVR outcomes in older adults, besides the improvement of 
echocardiographic parameters, should include also the assessment of changes in physical 
performance, in neurospichological and functional status, as well as in quality of life. 
Up to now, several studies have evaluated the effectiveness of AVR in older subjects in 
terms of peri- and post-operative mortality (26,27), but its impact on physical and mental 
performance  and global health has been scarcely investigated. 
We hypothesized that aortic valve replacement would worsen cognitive function in elderly 
patients due to anaesthesia, surgery and hospitalization. Moreover, that AVR could 
improve functional performance and quality of life in the medium-term.  
 
AIMS OF THE STUDY 
The aim of the present study was to assess the effects of AVR in elderly patients in relation 
to physical performance, cognition, and quality of life in the short- and medium term. 
Moreover, to assess the impact of pre-operatory functional status on physical performance. 
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SUBJECTS AND METHODS 
This observational prospective study was designed and conducted in collaboration between 
the Department of Medicine - Geriatric Section and the Cardiac Surgery Department of 
Padova University. 
Caucasian subjects aged >70 years affected by severe or symptomatic aortic valve stenosis 
with indication for isolated aortic valve replacement were recruited in the study. Subjects 
were not included only if they did not give their consent to participate to the study.  
The study was designed in accordance with the Helsinki Declaration. All participants were 
fully informed about the nature, purpose, procedures, and risks of the study and gave their 
informed consent.  
As illustrated in the flow chart (Figure 1), among 56 patients affected by AVS with 
indication for isolated valve replacement who referred to the Cardiac Surgery Department 
between January 2017 and August 2018, 10 refused to participate to the study, so 46 
subjects were enrolled in the study. For the present analysis we selected only patients who 
completed the 6-month follow up, so the considered sample is composed of 22 
participants. 
All subjects underwent sternotomic AVS. 
Subjects were evaluated by trained medical personnel before surgery (T0) and after VRS at 
45 days, 3 and 6 months (T1, T2, T3 visits, respectively). 
At each visit patients underwent a global clinical assessment and the following evaluations: 
− anthropometric measurements: body weight and stature were measured to the 
nearest 0.1 kg and 0.1 cm with a standard balance and stadiometer (Seca; Germany) 
with subjects wearing light clothing and no shoes. Their BMI was calculated as 
their weight in kilograms divided by the square of their stature in meters. 
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Circumferences were measured using a non-elastic but flexible plastic tape. Waist 
circumference was measured at the level of midway between the lowest rib and the 
top of the iliac crest. Mid-upper-arm circumference was measured using a flexible 
tape at the midway between the olecranon and acromial process on the upper right 
arm. Calf circumference was measured on the left leg in a sitting position with the 
knee and ankle at a right angle and feet resting on the floor. The calf circumference 
was measured at the point of greatest circumference. Subcutaneous tissues were not 
compressed; 
− comorbidities and indicators of disease severity: comorbidity was assessed using 
the Cumulative Illness Rating Scale (CIRS) (28), a validated physician-rated index 
calculated by collecting the subject’s medical history as well as conducting a 
physical examination and performing laboratory tests. The CIRS classifies 
comorbidities among 13 organ systems and grades each condition from 0 (no 
problem) to 4 (severely incapacitating or life-threatening conditions). The 
comorbidity index (CIRS-CI) is given by the number of conditions graded as  ≥ 3. 
The severity index (CIRS-SI) is the mean of the severity scores for each of the 13 
organ systems; 
- cognitive evaluation using: 
o Mini-Mental State Examination (MMSE) (29), a validated 
neuropsychological tool for measuring global cognitive function with 
orientation, concentration, language, praxis, and memory components. Total 
scores range from 0 (worst performance) and 30 (best performance). Crude 
MMSE scores obtained in our sample were adjusted for age and formal 
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education using coefficients proposed for the Italian population (30). 
Adjusted scores > 24 indicated a normal cognitive function (31); 
o Montreal Cognitive Assessment (MoCA) (32), a simple 10-min paper-and-
pencil test with a maximum score of 30. It assesses multiple cognitive 
domains including memory, language, executive functions, visuospatial 
skills, calculation, abstraction, attention, concentration, and orientation. A 
score ≥26 is considered normal; 
- affective status by means of the Geriatric Depression Scale (GDS) (33, a 30-item 
self-reporting tool for identifying depression that has been validated for use in the 
elderly. Scores <10 indicate absence of depression, scores 11-16 indicate a mild to 
moderate depression, and scores >17 indicate severe depression; 
- functional evaluation based on Activities of Daily Living (ADL) (34) and 
Instrumental Activities of Daily Living (IADL) (35) indexes. Given the 
traditionally different role of genders in Italian families, 3 items (preparing meals, 
doing housework, and doing laundry) were not applied to men. To make the values 
comparable, the IADL scores were calculated as percentages of the maximum 
value;  
- nutritional status was evaluated with the Mini-Nutritional Assessment (MNA) tool 
(36), an internationally validated method consisting of 18 items covering 
anthropometric measures, health status, dietary patterns, and subjective assessments 
of the participant’s nutritional and health status. A total score ≥ 23.5 distinguishes 
people with a good nutritional status from those at nutritional risk (MNA score 
between 17 and 23.5) and those with protein calorie malnutrition (MNA score < 
17); 
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- quality of life by means of the Short-Form 36 items health Survey (SF-36) (37), a 
test that comprises 36 multiple choice questions sorted into 8 subscales that 
describe overall health status. These subscales are physical functioning (PF), role 
limitations as a result of physical problems (RP), bodily pain (BP), general health 
perception (GH), vitality (the frequency of feeling full of energy vs feeling tired) 
(VT), social functioning (SF), role limitations resulting from emotional problems 
(RE), and general mental health (MH). Low numeric scores reflect a perception of 
poor health, loss of function, and presence of pain. High numeric scores reflect a 
perception of good health, no functional deficits, and absence of pain. SF-36 items 
were coded and scored as outlined in the SF-36 scoring manual and a score >50 for 
each item was considered as indicative of a “sufficiently” good perceived health 
status (38); 
- physical performance using: 
o Short Physical Performance Battery (SPPB) (39), which consists of 3 
objective physical function tests: 4-meter gait speed, repeated chair stands, 
and standing balance in increasingly challenging positions. Walking speed 
was calculated as the best performance achieved in two walks at the 
participant’s usual pace along a corridor 4-meter long. For the chair stands 
test, the participants were asked to rise 5 times from a seated position as 
quickly as possible with their hands folded across their chest. For the 
standing balance tests, participants were asked to stand in three increasingly 
difficult positions (with their feet side by side and in semitandem and full-
tandem positions) for 10 seconds each. Each test was scored from 0 (worst) 
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to 4 (best), and the scores from all three tests were combined to obtain a 
composite score of 0 to 12. Higher scores reflect better physical function; 
o 6-minute walking test (6-MWT) (40): participants were asked to walk at 
their usual pace for 6 minutes, and the distance they covered was recorded 
in meters. In evaluating changes in 6-MWT a threshold of 54 meters was 
considered as representative of clinically significant change; 
o measurement of handgrip strength on the dominant side by using DynEx 
electronic hand dynamometers. The participants were seated in a standard 
armchair with their shoulder adducted and neutrally rotated, their elbow 
flexed at 90°, and their forearm and wrist in a natural position. They were 
asked to grip the dynamometer smoothly, progressing up to their maximal 
strength in response to a voice command, without any wrenching or jerking 
motion. Three measurements were obtained on the dominant side with a 1-
minute rest between trials, and the highest measurement was used in our 
analyses. The handgrip endurance was determined by asking the subject to 
maintain 50% of maximal voluntary contraction for as long as he/she could 
and the time was recorded in seconds by using a stop watch (41); 
o measurement of isometric knee extension torque and isokinetic (flexion and 
extension) strength on the dominant side by using the dynamometer chair 
(Easytech s.r.l.). The participants were positioned upright with straps to fix 
their hips to the chair. For each of the 3 measurements, participants were 
asked to reach their maximal voluntary contraction. Three to five seconds 
after reaching their maximum effort, they were asked to stop the 
contraction. Each measurement was repeated three times, and patients 
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rested for 2 to 3 minutes between trials. The highest-peak torque (PT) was 
used for the analysis. 
 
Statistical analysis 
All measurements obtained at baseline and follow-up were used in the data analysis. 
Participants’ characteristics were summarized using mean ± standard deviation for 
continuous variables and counts and percentages for categorical variables. For continuous 
variables, normal distributions were tested using the Shapiro-Wilk test. The non-parametric 
Mann-Whitney test was used to check differences between medians of SPPB scores. 
Baseline characteristics were compared between genders by using independent t-tests, chi-
square tests, or Fisher’s exact test, as appropriate. Paired t-tests were used for within-group 
comparisons of baseline and follow up data. 
To assess which baseline characteristics were associated with a better global outcome 6 
months after surgery, we calculated a variable, Δ gate speed, obtained from T3 gate speed 
minus T0 gate speed. Furthermore, the variable Δ gate speed was dichotomized into > 0 
(indicating an improvement in gate speed at 6-month follow up vs baseline) and < 0 
(indicating a worsening). Pearson's correlation coefficient (r) was applied to measure 
simple linear associations between Δ gate speed and baseline characteristics of the 
subjects. 
All analyses were performed using SPSS 21.0 for Windows (SPSS Inc., Chicago, Illinois). 
All statistical tests were two-tailed and statistical significance was assumed for a p value 
<0.05. 
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RESULTS 
Baseline characteristics of the sample 
General characteristics of the sample grouped by sex are reported in Table 1. Men 
represented 54% of the study population. Men and women did not differ for BMI nor for 
echocardiographic parameters. The majority of both men and women was in NYHA class 
2, whether approximately 25% of them was in NYHA class 3. Angina and syncope were 
more prevalent in women but the difference did not reach statistical significance. 
Figure 2 illustrates the prevalence of comorbidities in the population sample. All women 
had hypertension and 88.8% of them had also dyslipidemia, whereas in men the prevalence 
of hypertension and dyslipidemia was 66.6% and 41.6%, respectively. Diabetes, atrial 
fibrillation and cerebrovascular diseases were more prevalent in men, whereas coronary 
heart disease and COPD were found more frequently in women. Nevertheless, these 
differences were not statistically significant. 
Regarding multidimensional assessment, CIRS-CI and CIRS-SI scores were significantly 
higher in women (4.5±0.9 and 1.9±0.2, respectively) than in men (3.5±1.1 and 1.7±0.1, 
respectively). MNA score was not significantly different between genders, but 33% of 
women and 8.3% of men were at risk of malnutrition (MNA score 17-23.5). 
MMSE score was not different between genders, with 1 woman and 1 man having a 
MMSE score < 24/30. MoCA score was significantly lower in women than men (21.5±4.4 
vs 24.9±2.3 respectively, p 0.041), with 88.9% of women and 45.5% of men having a 
MoCA score <26. 
GDS mean score was not significantly different in the two groups, but 63.6% of men and 
33.3% of women had a mild-to-moderate depression (GDS score 11-16), and 22.2% of 
women had a severe depression (GDS score >17). 
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ADL and IADL scores comparable between genders. 
Regarding physical performance tests, women covered a significantly lower distance 
compared with men (301.3±124.4 meters vs 442.9±71.7 meters, respectively, p = 0.004),  
and had lower values lower limbs performance and handgrip strength (21.3±7.2 Kg in 
women vs 42.8±9.8 Kg in men, p < 0.0001). 
Regarding quality of life, as showed in Figure 3, SF36 scores exploring physical 
functioning were higher in men (70.0±17.8 in men vs 48.3±29.1 in women, p 0.05), as well 
as scores related to physical role functioning (51.0±28.1 in men vs 28.9±35.0 in women, p 
= 0.01) and bodily pain (71.9±18.3 in men vs 48.4±11.8 in women, p = 0.004). In four 
SF36 items (physical functioning, bodily pain, emotional role functioning and mental 
health) the majority of subjects had a score > 50 (Figure 5). 
 
Comparison between baseline and 45-day follow up 
As reported in Table 2, 45 days after surgery subjects showed a significant worsening 
regarding nutritional aspects. Body weight decreased significantly (76.6±10.3 vs 73.9±0.8 
Kg, p 0.001), as well as arm circumference (28.5±3.4 vs 27.0±2.8 cm, p 0.014) and MNA 
score (25.0±1.8 vs 23.4±2.5, p 0.028). Calf and waist circumference did not change 
significantly. 
No variations were seen in cognitive function (MMSE, MoCA, GDS scores) and in 
functional status (ADL and IADL scores). 
Physical performance as explored by gait speed did not change significantly. During the 6-
MWT subjects covered a significantly lower distance compared to baseline (p 0.05), and  
among SPPB items, standing balance score decreased significantly compared to baseline (p 
0.05). Subjects with SPPB total score ≤8 increased from 9.5% to 21.1% (p 0.035). 
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Hangdrip maximal strength decreased significantly at 45-day follow up (33.7±14.4 vs 
29.9±11.1 Kg, p 0.008), as well as peak-torque extension (73.7±30.7 vs 65.2±30.4 Nm, p 
0.035), peak-torque flexion (32.1±15.1 vs 26.3±9.9 Nm, p 0.05) and isometric maximal 
strength (115.0±47.4 vs 97.9±39.0 Nm, p 0.001). 
Regarding quality of life measured by SF36 (Figure 4), physical functioning (60.6±26.2 vs 
51.5±19.8, p 0.043) and general health perceptions (60.0±20.7 and 49.9±17.0, p 0.05) 
worsened significantly. 
 
Comparison between baseline and 3-month follow up 
At 3-month follow up nutritional status was not significantly different from baseline (BMI, 
arm circumference, MNA score), as well as handgrip maximal strength, peak-torque 
extension and flexion. Isometric maximal strength was significantly lower than baseline 3 
months after surgery (101.3±45.9 vs 115.0±47.4 Nm, p 0.007). Also repeated chair stands 
score was significantly higher at 3-month compared to baseline (p 0.05). 
Mean GDS score did not change significantly, but the percentage of subjects with GDS 
score between 11 and 16 decreased significantly (40% vs 50%, p 0.05).   
Regarding quality of life (Figure 4), mental health score increased significantly (53.1±18.3 
vs 66.8±16.1, p 0.02). 
  
Comparison between baseline and 6-month follow up 
As reported in Table 2, at 6-month follow up BMI and anthropometric measurements (arm, 
calf and waist circumferences) were not different from baseline. MNA score increased 
significantly (25.0±1.8 vs 26.6±0.2, p 0.006). 
Regarding cognition, both MMSE and MoCA scores increased significantly (for MMSE 
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score: 26.6±2.2 vs 27.9±1.6, p 0.04; for MoCA score: 22.9±4.2 vs 25.0±2.4, p 0.016). GDS 
score was stable during follow up, but the percentage of subjects with GDS score between 
11 and 16 decreased significantly (23.9% vs 50%, p 0.038). 
Regarding functional status, the percentage of independent IADL increased at 6-month 
follow up (96.9±6.2 vs 98.2±12.4, p 0.004). 
Considering SPPB test, repeated chair stand score and SPPB total score increased 
significantly from baseline (p 0.05, p 0.05, and p 0.028, respectively). The percentage of 
subjects with SPPB total score ≤8 decreased significantly (4.8% vs 9.5%, p 0.025). Gait 
speed increased significantly (1.10±0.09 vs 0.94±0.23 m/s, p 0.05). 
At the 6-MWT the distance covered by subjects was not significantly different from 
baseline. 
The strength of arms and limbs was not different at follow up. 
Regarding quality of life (Figure 4), among SF36 items, physical role functioning score 
increased significantly (33.0±23.3 vs 63.1±21.1, p<0.0001), as well as vitality score 
(53.0±16.9 vs 63.5±17.6, p 0.013) and mental health score (53.1±18.3 vs 70.5±15.5, p 
0.001). In all SF36 items the majority of subjects had a score >50 (Figure 5). Compared to 
baseline, the prevalence of subjects with satisfactory scores was significantly higher than 
baseline in physical role functioning, vitality, social role functioning and mental health 
(Figure 5). 
 
Correlations between Δ gate speed and baseline characteristics of subjects 
As evidenced in Figure 6, a significant inverse relationship emerged between Δ gate speed 
and baseline peak torque extension (r: -0.789, p 0 0.007) as well as between Δ gate speed 
and baseline handgrip endurance 50% (r: -0.651, p = 0.042).  
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Figure 7 shows the mean values of peak torque extension and handgrip endurance in the 
sample divided by improvement or worsening in gate speed 6 months after surgery 
compared to baseline. Both parameters are significantly different at baseline between the 
two groups (p < 0.01). Peak torque extension values remained lower through the whole 
study in the group with Δ gate speed > 0 compared to the other subgroup. Regarding 
handgrip endurance, the group of patients with Δ gate speed > 0 had a significantly lower 
value at baseline compared to the other group, but at 6-month assessment their mean value 
was higher than the other subjects, even if not significantly different. 
As reported in Figure 7, also gait speed and 6-MWT distance at baseline were significantly 
lower in subjects with Δ gate speed > 0. At 6-month follow up this difference is nullified 
because of increasing results for the group with Δ gate speed > 0 and worsening results for 
subjects with Δ gate speed < 0. 
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DISCUSSION  
The present study explores the short- and medium-term impact of AVR on functional and 
neuropsychological status in elderly patients. Our data suggest that aortic valve replacement 
leads to an improvement in patients’ nutritional, neuropsychological and functional status and 
in perceived quality of life, whereas it does not have any significant impact on limbs muscle 
strength. 
In our sample, the majority of subjects was in NYHA II class, having slight limitation of 
physical activity due to dyspnoea, whereas about a fourth of them had a marked limitation of 
physical activity (NYHA class III). Angina and syncope were not highly prevalent in the 
study population.  
Echocardiography showed that all subjects had a normal left ventricle ejection fraction. 
Comorbidities more frequently associated with aortic valve stenosis were hypertension, 
dyslipidemia, diabetes, and atrial fibrillation, with a prevalence similar to that reported in 
other studies (42,43). Women had a significantly higher comorbidity burden compared to 
men, as evidenced by CIRS-CI and CIRS-SI scores, in accordance also with previous studies 
(44,45). 
From a nutritional point of view, subjects at baseline had a mean BMI of 28.4±4.3 
Kg/m
2
, indicative of normal weight – overweight. Nobody was underweight. Also mean 
MNA score was indicative of a normal nutritional status at baseline, but 28.6% of subjects 
were at risk for malnutrition (MNA score 17-23.5). These data are in line with those of 
Goldfarb et al. (46) who found 32.8% of subjects at risk for malnutrition among patients aged 
≥70 years who underwent AVR. Actually they found also 8.7% of malnourished patients, but 
in the study included not only subjects who underwent surgical AVR but also transcatheter 
AVR (TAVR), an option dedicated to high risk patients who would be otherwise excluded 
from surgical AVR. Among patients undergoing general surgery, malnutrition is associated 
with delayed wound healing, postoperative complications, prolonged hospital length of stay, 
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hospital readmission, and death (47,48). Regarding AVR, Goldfarb et al. (46) demonstrated 
that malnourished patients had a 3-fold higher crude risk of 1-year mortality compared with 
those with normal nutritional status. Furthermore, Chermesh et al. (49) found that 
incorporation of the nutritional assessment in the EuroSCORE significantly improved 
prediction of postoperative complications and in-hospital and 30-day mortality, compared 
with the EuroSCORE alone.  
Surgical intervention had a great impact on nutritional status of our elderly subjects. At 45-
day follow up, body weight decreased by 2.6±2.0 Kg and the proportion of subjects at risk for 
malnutrition almost doubled (52.6%). This weight loss is probably due to a reduction in 
calorie intake and hypermetabolism, as demonstrated also by Sallè et al. (50). In our sample, 
this worsening was reversible. In fact, at 3-month assessment body weight, BMI, MNA score 
and the percentage of subjects at risk for malnutrition were not different from baseline. 
Moreover, at 6-month follow up MNA score increased significantly and nobody was at risk 
for malnutrition.  
To explore cognitive status we used two tests, MMSE and MoCA, since that the latter 
is more sensitive to subtle cognitive deficits than MMSE (51). In fact, according to MMSE 
score, almost all subjects were considered to have a normal cognition, while MoCA detected 
impaired cognition in 80% of the sample at baseline.  
Since that AVR requires general anaesthesia, our preliminary hypothesis was that surgical 
intervention, in addition to hospitalization, could worsen cognitive performance in elderly 
subjects. Actually it was not like that. Not only MMSE and MoCA scores did not decrease at 
45-day follow up, but they improved significantly at 6-month assessment compared to 
baseline. Also Knipp et al. (52), who studied 64 elderly patients with aortic stenosis 
undergoing aortic valve replacement, found that surgical intervention did not significantly 
change neuropsychological tests scores between baseline and 3-months. 
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Regarding mood, mean GDS score at baseline was 12.4±3.4, indicative of mild-to-moderate 
depression (GDS 11-16). Fifty percent of subjects had a score between 11 and 16, and 10% 
resulted as severely depressed. Immediately after surgery the prevalence of depressed 
subjects increased, but at 6-month follow up patients with mild-to moderate depression 
halved, whereas those with severe depression maintained proportionally stable.   
Among physical performance tests, in our sample baseline SPPB score was 11 
(interquartile range 8-12). Despite a very high score, 9.5% of subjects at baseline had an 
SPPB total score ≤8, the cut off commonly used for the diagnosis of sarcopenia (53). 
Immediately after surgery, the proportion of subjects with an SPPB score ≤8 increased 
significantly to 21.1% but at 6-month follow up decreased to 4.8%, which was significantly 
lower than baseline. Also repeated chair stands score and 4-meter gait speed at 6 months 
were better than before surgery. This functional improvement in the medium-term after AVR 
is particularly interesting since that SPPB test is considered a nonspecific but highly sensitive 
indicator of global health status (54). Moreover, this test has a strong and independent ability 
to predict mortality, morbidity and hospitalization in older adults (53,55), so an improvement 
in SPPB score may lead in the long term to a better capability of patients to react to future 
stressors.  
The observed transient worsening in standing balance at 45 days after surgery may be an 
early consequence of deconditioning and muscle atrophy due to surgery and bed rest, which 
leads to muscle atrophy preferentially involving the anti-gravity muscle groups which are 
very important for posture (56,57).  
Regarding gait speed, it is recognized as a valuable predictor for the onset of adverse 
health events (severe mobility limitation, mortality) in community-living elderly people (53), 
but also in patients undergoing cardiac surgery (26). Its importance has also been highlighted 
by the American College of Cardiology, which recommends that gate speed test be used to 
assess frailty and physical functioning when determining a patient’s suitability for 
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transcatheter AVR (27). Considering the recognized importance of this indicator of global 
health status, we chose to examine 6-month variations in gait speed in relation to baseline 
characteristics of patients. We found that Δ gate speed was inversely correlated with basal 
peak torque extension and with baseline handgrip endurance (Figure 6). In other words, 
subjects with a basal lower level of physical performance were those who had a greater 
benefit in terms of gaining gait speed after AVR. Successively, we divided the sample in two 
groups depending on the presence of improvement or worsening in gait speed. We found that 
subjects who improved in gait speed, at baseline had a globally worse performance (Figure 
7): in fact, they had lower baseline values of peak torque extension, handgrip endurance, gait 
speed and 6-MWT. Moreover, subjects who improved in gait speed, improved also in 
handgrip endurance and 6-MWT. To our knowledge, up to now, only Kotajarvi et al. (58) 
evaluated the effect of AVR on physical performance. They studied 103 elderly subjects 
using self-reported measures of functional capacity and found that 3 months after surgery 
patients with a greater improvement were those with a lower performance at baseline. These 
results evidence that pre-operatory assessment should not exclude a priori subjects with a 
worse physical performance, since that they could be the ones who have a greater global 
health benefit from AVR. 
In the assessment of waking ability, the 6-MWT differs from gait speed in that 
provides a global assessment of endurance capacity (59), being influenced not only by 
musculoskeletal factors but also by cardiopulmonary compliance. In our sample, 6-MWT did 
not show any significant variation between baseline and 6-month follow up. However,  25% 
of subjects at 6-month visit had an improvement > 54 meters, which is commonly considered 
as clinically significant.  The fact that only 25% of patients showed a clinically significant 
improvement in 6-MWT is due to the high mean performance at baseline. In fact, the group 
of patients who did not improve in 6-MWT, compared to patients who improve, at baseline 
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covered a significantly higher distance (400.1±90.0 m vs 298.4±98.2 m, respectively; p 
0.038). 
Regarding upper and lower limbs strength, muscle function is important in the 
elderly: low levels of muscle strength in fact are significantly associated with various 
negative outcomes in older people, such as falls, fractures, functional limitations in activities 
of daily living, and death (60-65). Baseline values of our sample were comparable with those 
of the general population (66-69). At the first follow up visit upper and lower limbs strength 
significantly reduced as a consequence of surgery and bed rest, but at 3- and 6-month control 
they were not different from baseline. Hence, the improvement in functional performance 
after AVR evidenced by SPPB and gait speed is not related to the improvement in muscle 
strength, but it reflects a better global health status.   
Finally, regarding quality of life (QoL), at baseline the majority of subjects had a 
score < 50 in four SF36 items. Immediately after surgery perceived QoL decreased in nearly 
all domains, but at subsequent visits al the scores improved and at 6 month scores were 
higher than baseline. As reported in Figure 5, six months after surgery the percentage of 
subjects with SF36 items scores > 50 increased, and the majority of subjects had a sufficient 
perceived QoL in all SF36 items. In particular, the improvement was significant for physical 
role functioning (i.e. problems encountered with daily activities or work as a result of 
physical health), vitality (i.e. a general measure of energy/fatigue), social role functioning 
(i.e. the ability to perform social activities in lieu of health problem) and mental health (i.e. 
the emotional, cognitive and intellectual status of the patient). Postoperative health-related 
QoL is a primary goal of surgery in the elderly and an important aspect for many patients in 
their decision-making. The challenge of surgery in this population is to provide a good QoL 
in the mid- to long-term (70,71). Shan et al. (72) performed a systematic review on the QoL 
benefits after AVR and found that elderly patients improve in QoL scores after surgery 
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compared to baseline, and have equal or better QoL compared with an age-matched 
population. 
 The present study has some limitations. First of all, the number of subjects that 
completed the 6-month follow up is restricted so the results should be confirmed after 
increasing the sample size. Secondly, due to the very low mortality rate (only one person), we 
are unable to assess possible associations between baseline performance status and mortality. 
Actually, a low mortality rate is a positive outcome. Moreover, all patients underwent median 
sternotomy, so we do not have a comparison group treated with transcatheter aortic valve 
implantation, that could have a different functional impact on elderly subjects, being less 
invasive. 
 
Conclusions  
In conclusion, our data show that aortic valve replacement in elderly subjects do not have 
negative effects on cognition and depression; on the contrary, the intervention leads in the 
medium-term to an improvement in neuropsychological scores. Also nutritional status seems 
to take advantage from AVR, as demonstrated by the improvement in MNA score in addition 
to the reduction in the percentage of people at risk for malnutrition at 6-month follow up. 
Regarding physical performance, aortic valve replacement leads to a significant improvement 
in SPPB and in gait speed, which are considered indicators of good global health status. This 
functional improvement occurred without an increase in limbs muscle strength, as measured 
by handgrip and femoral quadriceps flexion and extension strength. Moreover, subjects who 
had a greater benefit from AVR were those with a worse performance at baseline.  
Finally, all subjects in the middle-term perceived a better quality of life compared to baseline, 
in particular concerning physical role functioning, vitality, social role functioning and mental 
health.  
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Table 1. General characteristics of subjects at baseline by gender. 
 Women 
(n = 10) 
Men 
(n = 12) 
p-value  
(Women vs Men) 
Age (ys) 76.4±2.7 76.7±4.5 n.s. 
Height (m) 1.55±0.06 1.70±0.09 <0.0001 
Body weight (Kg) 72.2±7.64 80.4±10.6 0.05 
NYHA class I (%) 0 0 n.s. 
NYHA class II (%) 77.7 75.0 n.s. 
NYHA class III (%) 22.3 25.0 n.s. 
NYHA class IV (%) 0 0 n.s. 
Angina, % 22.2 16.6 n.s. 
Sincope, %  11.1 0.0 n.s. 
Echocardiographic parameters 
   
    Aortic valve area (cm
2
) 1.40±0.52 1.49±0.58 n.s. 
    Indexed aortic valve area (cm
2
/m
2
) 0.57±0.20 0.52±0.20 n.s. 
    Peak transaortic pressure gradient (mmHg) 83.11±27.55 73.96±15.40 n.s. 
    Mean transaortic pressure gradient (mmHg)   51.27±17.03 46.24±10.98 n.s. 
    Left ventricular ejection fraction (%) 62.2±8.0 59.0±9.4 n.s. 
Multidimensional assessment 
Comorbidities 
   
     CIRS-CI score 4.5±0.9 3.5±1.1 0.035 
     CIRS-SI score 1.9±0.2 1.7±0.1 0.050 
Nutritional assessment    
     BMI (Kg/m
2
)  30.4±4.9 27.4±3.3 n.s. 
     Arm circumference (cm) 28.9±4.4 28.4±2.4 n.s. 
     Calf circumference (cm) 35.4±5.2 35.4±3.6 n.s. 
     Waist circumference (cm) 98.7±16.5 102.6±10.0 n.s. 
     MNA score 24.3±1.7 25.7±1.9 n.s. 
Cognitive status and mood evaluation    
     MMSE score 27.2±2.5 27.0±1.7 n.s. 
     MoCA score 21.5±4.4 24.9±2.3 0.041 
     GDS score 12.6±4.5 11.2±2.8 n.s. 
Functional status    
     ADL independent 5.6±0.5 5.9±0.3 n.s. 
     IADL independent % 95.8±6.2 98.3±5.7 n.s. 
Physical performance    
     SPPB [median (IQR)]    
         Standing balance score 4 (4-4) 4 (3-4) n.s. 
         4-meter gait speed score 3 (3-4) 4 (3-4) 0.05 
         Repeated chair stands score 4 (1-4) 4 (3-4) n.s. 
         Total score 11 (8-12) 11 (9-12) n.s. 
     Gait Speed (m/s)  1.02±0.82 0.82±0.21 n.s. 
     6-MWT (m) 301.3±124.4 442.9±71.7 0.004 
     Handgrip maximal strength (Kg) 21.3±7.2 42.8±9.8 <0.0001 
     Handgrip endurance (sec)  94.8±70.2 81.1±35.8 n.s. 
     Peak-torque extension (Nm) 50.4±5.8 91.0±28.2 <0.0001 
     Peak-torque flexion (Nm) 21.3±7.6 40.1±15.2 0.003 
     Isometric maximal strength (Nm) 78.2±16.4 140.1±42.9 <0.0001 
NYHA: New York Heart Association; CIRS: Cumulative Illness Rating Scale (CI: Comorbidity Index; SI: 
Severity Index); BMI: Body Mass Index; MNA: Mini Nutritional Assessment; MMSE: Mini Mental State 
Examination; MoCA: Montreal Cognitive Assessment; GDS: Geriatric Depression Scale; ADL: Activities of 
Daily Living; IADL: Instrumental Activities of Daily Living; SPPB: Short Physical Performance Battery; IQR: 
interquartile range; 6-MWT: six-minute walking test. 
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Table 2. General characteristics of the sample (n=22) at baseline and during follow up (FU). 
 
 Baseline 
(T0) 
45-days FU 
(T1) 
3-month FU 
(T2) 
6-month FU 
(T3) 
p-value 
(T0 vs T1) 
p-value 
(T1 vs T2) 
p-value 
(T2 vs T3) 
p-value 
(T0 vs T2) 
p-value 
(T0 vs T3) 
Indexed aortic valve area (cm
2
/m
2
) 0.51±0.10 0.83±0.15 1.35±0.20 1.32±0.18 0.03 0.01 n.s. 0.002 0.002 
Peak transaortic pressure gradient (mmHg) 72.6±14.7 20.6±9.7 20.0±5.0 15.0±4.4 <0.0001 n.s. n.s. <0.0001 <0.0001 
Mean transaortic pressure gradient (mmHg)   43.8±9.5 12.0±6.3 10.1±4.9 14.0±2.6 <0.0001 n.s. n.s. <0.0001 <0.001 
Left ventricular ejection fraction (%) 58.0±9.7 54.1±6.7 55.4±6.1 58.7±6.5 n.s. n.s. n.s. n.s. n.s. 
 
Multidimensional assessment 
         
Nutritional assessment          
     Body weight (Kg) 76.6±10.3 73.9±10.8 75.4±11.9 76.7±11.5 0.001 0.001 0.015 n.s. n.s. 
     BMI (Kg/m
2
)  28.4±4.3 27.7±4.8 34.4±28.0 28.5±5.0 0.037 n.s. 0.016 n.s. n.s. 
     Arm circumference (cm) 28.5±3.4 27.0±2.8 28.3±2.5 28.6±0.6 0.014 n.s. n.s. n.s. n.s. 
     Calf circumference (cm) 35.1±4.3 34.3±4.7 35.8±3.6 35.8±0.5 n.s. n.s. n.s. n.s. n.s. 
     Waist circumference (cm) 100.3±13.4 98.1±11.4 100.3±11.2 101.1±2.7 n.s. n.s. n.s. n.s. n.s. 
     MNA score 25.0±1.8 23.4±2.5 25.4±2.1 26.6±0.2 0.028 0.003 0.030 n.s. 0.006 
           MNA score 23.5-17 (%) 28.6 52.6 28.6 0.0 0.015 0.018 0.002 n.s. 0.001 
           MNA score <17 (%) 0.0 0.0 0.0 0.0 n.s. n.s. n.s. n.s. n.s. 
Cognitive status and mood evaluation          
     MMSE score 26.6±2.2 26.6±2.2 27.3±1.9 27.9±1.6 n.s. n.s. 0.050 n.s. 0.040 
           MMSE score <24/30 (%) 5.0 5.0 0.0 0.0 n.s. n.s. n.s. n.s. n.s. 
     MoCA score 22.9±4.2 24.1±3.4 24.1±2.9 25.0±2.4 n.s. n.s. n.s. n.s. 0.016 
           MoCA score <26/30 (%) 80.0 71.4 73.3 76.2 n.s. n.s. n.s. n.s. n.s. 
     GDS score 12.4±3.4 11.3±3.8 11.7±4.6 10.7±4.4 n.s. n.s. n.s. n.s. n.s. 
           GDS score 11-16 (%) 50.0 53.5 40 23.9 n.s. n.s. n.s. 0.05 0.038 
           GDS score >16 (%) 10.0 14.2 13.4 14.3 n.s. n.s. n.s. n.s. n.s. 
Functional status          
     ADL independent 5.7±0.41 5.6±0.6 5.8±0.5 5.9±0.0 n.s. n.s. n.s. n.s. n.s. 
     IADL independent % 96.9±6.2 90.2±18.5 93.9±11.9 98.2±12.4 n.s. n.s. n.s. n.s. 0.004 
Physical performance          
     SPPB [median (IQR)]          
         Standing balance score 4 (4-4) 4 (3-4) 4 (3-4) 4 (4-4) 0.05 0.048 n.s. n.s. n.s. 
         4-meter gait speed score 4 (3-4) 4 (3-4) 4 (3-4) 4 (4-4) n.s. n.s. n.s. n.s. 0.05 
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 Baseline 
(T0) 
45-days FU 
(T1) 
3-month FU 
(T2) 
6-month FU 
(T3) 
p-value 
(T0 vs T1) 
p-value 
(T1 vs T2) 
p-value 
(T2 vs T3) 
p-value 
(T0 vs T2) 
p-value 
(T0 vs T3) 
         Repeated chair stands score 4 (2-4) 4 (3-4) 4 (3-4) 4 (3-4) n.s. n.s. n.s. 0.05 0.05 
          Total score 11 (8-12) 12 (9-12) 11 (9-12) 12 (11-12) n.s. n.s. 0.038 n.s. 0.028 
          Subjects with SPPB total score ≤8 (%) 9.5 21.1 14.3 4.8 0.035 n.s. n.s. n.s. 0.025 
     Gait Speed (m/s)  0.94±0.23 0.90±0.20 0.91±0.20 1.10±0.09 n.s. n.s. n.s. n.s. 0.05 
     6-MWT (m) 380.0±12.7 361.0±12.4 383.0±19.4 390.5±25.2 0.05 0.048 n.s. n.s. n.s. 
     Handgrip maximal strength (Kg) 33.7±14.4 29.9±11.1 31.7±13.9 33.5±3.0 0.008 n.s. 0.010 n.s. n.s. 
     Handgrip endurance (sec)  88.8±55.4 78.0±38.4 81.6±41.2 75.9±7.8 n.s. n.s. n.s. n.s. n.s. 
     Peak-torque extension (Nm) 73.7±30.7 65.2±30.4 72.1±30.6 73.9±7.3 0.035 n.s. n.s. n.s. n.s. 
     Peak-torque flexion (Nm) 32.1±15.1 26.3±9.9 31.1±16.3 34.1±5.1 0.05 n.s. n.s. n.s. n.s. 
     Isometric maximal strength (Nm) 115.0±47.4 97.9±39.0 101.3±45.9 104.5±8.4 0.001 n.s. n.s. 0.007 n.s. 
 
BMI: Body Mass Index; MNA: Mini Nutritional Assessment; MMSE: Mini Mental State Examination; MoCA: Montreal Cognitive Assessment; GDS: Geriatric 
Depression Scale; ADL: Activities of Daily Living; IADL: Instrumental Activities of Daily Living; SPPB: Short Physical Performance Battery; IQR: interquartile 
range; 6-MWT: six-minute walking test. 
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Figure 1. Flow chart illustrating patients selection process. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AVS: aortic valve stenosis; AVR: aortic valve replacement; 
 
  
56 subjects affected by AVS with indication 
to isolated AVR referring to the Cardiac 
Surgery Department of Padova University 
between January 2017 and August 2018 
10 refused to 
participate to the 
study 
46 Subjects enrolled in the study and evaluated at 
baseline 
‒ 30 reached 3-month follow up; 
‒ 22 concluded 6-month follow up; 
‒ 7 concluded 12-month follow up. 
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Figure 2. Prevalence of comorbidities in subjects at baseline by gender. 
 
 
Figure legend 
Hyper: hypertension; Dyslip: dyslipidemia; AF: atrial fibrillation; CA: carotid 
atherosclerosis; PAD: peripheral artery disease; CHD: coronary heart disease; MI: 
myocardial infarction; COPD: chronic obstructive pulmonary disease. 
* p < 0.05 
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Figure 3. SF36 scores at baseline in subjects divided by gender. 
 
 
Figure legend 
PF: physical functioning; PR: physical role functioning; BP: bodily pain; GH: general 
health perceptions; VI: vitality; SR: social role functioning; ER: emotional role 
functioning; MH: mental health. 
* p < 0.05; ** p < 0.01 
 
  
0 
20 
40 
60 
80 
100 
PF PR BP GH VI SR ER MH 
Women 
Men * ** ** 
  
42 
 
Figure 4. Mean score obtained by the studied population in SF36 items at baseline 
(T0) and during follow up.  
Figure legend 
For T0 vs T1, §: p <0.05; for T1 vs T2, *: p <0.05, **: p <0.01; for T2 vs T3, °: p <0.05, °°: 
p <0.01, °°°: p <0.001;  for T0 vs T2, #: p <0.05; for T0 vs T3, ^^: p <0.01, ^^^: p <0.0001. 
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Figure 5. Comparison between percentage of subjects with SF36 items score > 50 at 
baseline vs 6-month follow up. 
 
 
 
Figure legend 
PF: physical functioning; PR: physical role functioning; BP: bodily pain; GH: general 
health perceptions; VI: vitality; SR: social role functioning; ER: emotional role 
functioning; MH: mental health. 
** p < 0.01 
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Figure 6. Significant correlations between gate speed variations (6-month vs baseline) 
and baseline characteristics of subjects. 
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Figure 7. Mean peak torque extension, handgrip endurance, gait speed, SPPB score 
and 6-MWT distance in subjects divided by change in gate speed (6-month vs 
baseline) at each assessment visit. 
 
 
 
 
 
